SORTILINHEMMER

European patent · EP4405334 · In force

Register entry

Publication number
EP4405334
Application number
EP22822701
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 1, 2022
Published
Jul 31, 2024
Granted
Feb 12, 2025
Protection ends at the latest
Nov 30, 2042
Next annual fee due
Dec 31, 2026
IPC classes
C07D 207/34 (2006.01)
C07D 209/42 (2006.01)
C07D 213/78 (2006.01)
C07D 231/14 (2006.01)
C07D 233/18 (2006.01)
C07D 239/557 (2006.01)
C07D 241/18 (2006.01)
C07D 249/08 (2006.01)
C07D 257/04 (2006.01)
C07D 261/10 (2006.01)
C07D 275/03 (2006.01)
C07D 277/56 (2006.01)
C07D 333/12 (2006.01)
C07D 333/24 (2006.01)
C07D 333/38 (2006.01)
Priority
SE 2151469 02.12.2021
PCT application
PCT/SE2022/051131 01.12.2022
PCT publication
WO2023/101595 08.06.2023
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Dec 24, 2025

    Change

    Published in Swissreg on 24.12.2025

  3. Feb 12, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 12.02.2025

Parties

Holder

Sortina Pharma AB

Erik Dahlbergsgatan 11 A, 411 26 Göteborg, SE

Inventor

RHOST, Sara

431 63 Mölndal, SE

LANDBERG, Göran

302 70 Halmstad, SE

WESTERLUND, Christer

431 50 Mölndal, SE

OLSSON, Thomas

423 61 Torslanda, SE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.